Device Trial Radar · NCT07828730
Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Dec 2027
Study completion Mar 2028
Sponsor
- Lead sponsor
- Sunnybrook Health Sciences CentreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- KMH Cardiology and Diagnostic Centres; Sparrow Acoustics Inc.; Ontario Health; Canadian Cardiovascular Society; Edwards life sciences; Medtronic
- First posted
- Sep 18, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- No
- Who can join
- All sexes, from 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this research is to look at an approved intervention (Stethophone application) to obtain additional information about improving detection of moderate or severe aortic stenosis when compared with usual standard of care.
Conditions
- Moderate or Severe Aortic Stenosis
Interventions
StethophoneDevice
Stethophone is a smartphone application developed by Sparrow Acoustics Inc. It turns a smartphone into a digital stethoscope. Stethophone is cleared by the U.S. FDA and licensed by Health Canada to record heart sounds and detect heart murmurs. It is not cleared or licensed to diagnose aortic stenosis. In this study, Stethophone is used as a digital auscultation decision-support device, and its output is not a diagnosis. An abnormal result prompts transthoracic echocardiography, which is used to confirm moderate or severe aortic stenosis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of new diagnosis of moderate or severe aortic stenosis on transthoracic echo/1000 patients screened of patients over 70 yearsTime frame: Within 3 months after enrolment.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.